{"nct_id":"NCT00718601","title":"Safety and Dose Study of GRN163L and Velcade to Treat Patients With Refractory or Relapsed Myeloma","status":"COMPLETED","status_verified_date":"2015-12","start_date":"2008-07","start_date_type":null,"primary_completion_date":"2011-10","primary_completion_date_type":"ACTUAL","completion_date":"2011-10","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GERN"]}